Last September, the FIBRONEER-IPF trial also showed an improvement in lung function with the drug in patients with idiopathic pulmonary fibrosis ... Ofev, for example, causes gastrointestinal ...

A new drug for pulmonary fibrosis has reduced ... By definition, the term is used only when the cause of the pulmonary fibrosis is unknown ("idiopathic"). Microscopically, lung tissue from ...

DelveInsight Logo Although the cause of IPF is unknown ... Learn more about the FDA-approved IPF drugs @ Drugs for Idiopathic Pulmonary Fibrosis Treatment Pirfenidone reduces the likelihood ...

A small study published in Nature Medicine reported encouraging results for personalized inhaled bacteriophage therapy in ...

Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a ... that an FDA-approved cancer drug may help the immune system clear out the ...

An Insilico Medicine drug candidate spawned by the ... The disease is idiopathic pulmonary fibrosis (IPF), a chronic disorder that causes scarring in the lungs and an irreversible decline in ...

the treatment options remain limited to two anti-fibrotic medications, which can only slow the progression of lung tissue scarring. "Idiopathic means the cause is unknown. Pulmonary fibrosis can ...

Chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis (also called idiopathic ... Smoking is the main cause. You might be at higher risk for COPD if you have asthma or breathe ...